ARCHIVES

Blincyto Demonstrates Response In Minimal Residual Disease ALL

This article is from The Cancer Letter archive.

Vol. 37 No. 12 | December 26, 2014

Download PDF Visit The Full Archive

Related Articles

Herceptin With Adjuvant Chemo Improves Disease-Free Survival, Phase III Trial Finds

January 29, 2010

In Brief: NIH Alumni Assn. Formed; Jenney Named Kans. Vice Chancellor; Bloomfield To Move To RPMI

June 9, 1989

AACR, ASCO Continue Growth, Drop Idea Of “Cancer Week”

July 1, 1988

NCi Advisors Approve New SPORE Grant Program In Cancer Communications.

December 1, 2000

DCPC Advisors Consider Asking DRG For Section On Prevention & Control

May 14, 1993

In Brief: Elizabeth Miller Dies; Mihich Names Associate Director At RPMI; AACR Calls For Abstracts

October 23, 1987